1. Home
  2. GOSS vs IIIV Comparison

GOSS vs IIIV Comparison

Compare GOSS & IIIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gossamer Bio Inc.

GOSS

Gossamer Bio Inc.

N/A

Current Price

$0.50

Market Cap

615.7M

Sector

Health Care

ML Signal

N/A

Logo i3 Verticals Inc.

IIIV

i3 Verticals Inc.

N/A

Current Price

$23.08

Market Cap

642.1M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
GOSS
IIIV
Founded
2015
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
615.7M
642.1M
IPO Year
2018
2018

Fundamental Metrics

Financial Performance
Metric
GOSS
IIIV
Price
$0.50
$23.08
Analyst Decision
Buy
Strong Buy
Analyst Count
9
5
Target Price
$4.91
$33.20
AVG Volume (30 Days)
27.3M
392.0K
Earning Date
01-01-0001
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
78.81
N/A
EPS
N/A
0.02
Revenue
$114,701,000.00
N/A
Revenue This Year
N/A
$9.05
Revenue Next Year
N/A
$8.07
P/E Ratio
N/A
$1,176.50
Revenue Growth
N/A
N/A
52 Week Low
$0.33
$19.89
52 Week High
$3.87
$33.97

Technical Indicators

Market Signals
Indicator
GOSS
IIIV
Relative Strength Index (RSI) 23.06 51.97
Support Level $0.33 $22.51
Resistance Level $1.23 $23.36
Average True Range (ATR) 0.09 0.80
MACD -0.00 0.25
Stochastic Oscillator 8.98 65.43

Price Performance

Historical Comparison
GOSS
IIIV

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

About IIIV i3 Verticals Inc.

i3 Verticals Inc provides mission-critical enterprise software solutions to public sector entities. These comprehensive cloud-native solutions address a broad range of government functions, including courts and public safety, public administration, utilities, transportation and schools. The company generates the majority of revenue from software and related services, including the sale of subscriptions, recurring services, ongoing support, licenses, and installation and implementation services specific to software.

Share on Social Networks: